Asia Pacific Parenteral Nutrition Market Forecast to 2030

At 6.9% CAGR, Asia Pacific Parenteral Nutrition Market is Speculated to be Worth US$ 1,471.33 Million by 2030, says the Research Team

According to the Research Team’ research, the Asia Pacific parenteral nutrition market was valued at US$ 861.59 million in 2022 and is expected to reach US$ 1,471.33 million by 2030, registering a CAGR of 6.9% from 2022 to 2030. Surge in cases of malnutrition and premature births and innovation in formulations of nutrition products are among the critical factors attributed to the Asia Pacific parenteral nutrition market expansion.

Malnutrition includes being undernourished, overweight or obese, having inadequate vitamins or minerals, and having a non-communicable disease due to a bad diet. As per World Health Organization (WHO) data, ~1.9 billion adults were overweight or obese, whereas 462 million were underweight in 2021. Additionally, 39 million children under the age of 5 were overweight, 149 million had stunted growth and development as a result of a chronic lack of nutrient-rich food in their diets, and 45 million were wasted (too thin for height). Furthermore, ~45% of deaths among children aged less than 5 are associated with undernutrition. As per the July 2022 data of the United Nations International Children’s Emergency Fund (UNICEF), the prevalence of undernourishment reached 9.3% in 2020 from 8.0% in 2019; it further jumped to 9.8% in 2021.

Nutritional support delivered through parenteral methods, depending on the need, is an important and appropriate way of treating most malnutrition cases.

Preterm birth refers to a baby being born at a significantly early stage, i.e., before the completion of 37 weeks of pregnancy. As per the WHO data published in 2023, ~13.4 million preterm births (more than 1 in 10 births) were reported worldwide in 2020. Additionally, most preterm births (more than 60%) occurred in southern Asia and sub-Saharan Africa in 2021, which is becoming a global concern. On average, 12% of babies in low-income countries are born too early, compared to 9% in high-income countries. A large number of premature babies suffer from low weight and undeveloped immunity, which puts their lives at risk. Parenteral nutrition is preferred in preterm infants due to sucking or swallowing difficulties as a complication of an immature birth or due to neuromuscular, heart, or other disorders. When estimated energy and nutritional requirements cannot be safely met by enteral route right after birth, parenteral nutrition (PN) is part of the routine nutrition care for premature neonates and infants.

Thus, the huge burden of malnutrition in children and adults and the high number of preterm births drive the demand for parenteral nutrition formulae and products, which drives the market.

On the contrary, mechanical, gastrointestinal, and metabolic complications associated with parenteral feeding systems hampers the growth of Asia Pacific parenteral nutrition market.

Based on nutrient type, the Asia Pacific parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held 33.2% market share in 2022, amassing US$ 285.70 million. It is projected to garner US$ 484.20 million by 2030 to register 6.8% CAGR during 2022-2030.

In terms of end user, the Asia Pacific parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held 59.5% share of Asia Pacific parenteral nutrition market in 2022, amassing US$ 512.36 million. It is projected to garner US$ 856.52 million by 2030 to expand at 6.6% CAGR during 2022-2030.

Based on country, the Asia Pacific parenteral nutrition market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 27.4% share of Asia Pacific parenteral nutrition market in 2022. It was assessed at US$ 235.94 million in 2022 and is likely to hit US$ 416.07 million by 2030, exhibiting a CAGR of 7.3% during 2022-2030.

Key players operating in the Asia Pacific parenteral nutrition market are ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, and Vifor Pharma Management AG, among others.

In November 2020, Otsuka Pharmaceuticals Co Ltd launched “ENEFLUID Injection,” the amino acid, glucose, electrolyte, fat, and water-soluble vitamin injection. This product is the first peripheral parenteral nutrition solution in Japan that combines fat and water-soluble vitamins in addition to glucose, electrolytes, and amino acids in a dual-chamber bag.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific parenteral nutrition market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific parenteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific parenteral nutrition market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Parenteral Nutrition Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rise in Prevalence of Gastrointestinal Diseases
4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
4.3.1 New Product Developments by Companies
4.4 Future Trends
4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis
5. Parenteral Nutrition Market – Asia Pacific Market Analysis
5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 – 2030
6. Asia Pacific Parenteral Nutrition Market Analysis – by Nutrient Type
6.1 Overview
6.2 Single Dose Amino Acid Solution
6.2.1 Overview
6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
6.3.1 Overview
6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
6.4.1 Overview
6.4.2 Carbohydrates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
6.5.1 Overview
6.5.2 Trace Elements: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
6.6.1 Overview
6.6.2 Vitamins and Minerals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Parenteral Nutrition Market Analysis – by End User
7.1 Overview
7.2 Hospitals
7.2.1 Overview
7.2.2 Hospitals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
7.3.1 Overview
7.3.2 Clinics: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Parenteral Nutrition Market – Country Analysis
8.1 Asia Pacific
8.1.1 Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast Analysis – by Country
8.1.1.1 China: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 China: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 China: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.1.4 China: Parenteral Nutrition Market Breakdown, by End User
8.1.1.2 Japan: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 Japan: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 Japan: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.2.4 Japan: Parenteral Nutrition Market Breakdown, by End User
8.1.1.3 India: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 India: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 India: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.3.4 India: Parenteral Nutrition Market Breakdown, by End User
8.1.1.4 Australia: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.1 Overview
8.1.1.4.2 Australia: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.3 Australia: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.4.4 Australia: Parenteral Nutrition Market Breakdown, by End User
8.1.1.5 South Korea: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.5.1 Overview
8.1.1.5.2 South Korea: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.5.3 South Korea: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.5.4 South Korea: Parenteral Nutrition Market Breakdown, by End User
8.1.1.6 Rest of Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.6.1 Overview
8.1.1.6.2 Rest of Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.1.1.6.3 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.6.4 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by End User
9. Industry Landscape
9.1 Overview
9.1.1 Overview
10. Company Profiles
10.1 ICU Medical Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Grifols SA
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Pfizer Inc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Baxter International Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 B Braun SE
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Fresenius Kabi AG
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Vifor Pharma Management AG
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Aculife Healthcare Pvt Ltd
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The the Reporting Teams
11.2 Glossary of Terms

LIST OF TABLES

Table 1. Parenteral Nutrition Market Segmentation
Table 2. China: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 3. China: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 4. Japan: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 5. Japan: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 6. India: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 7. India: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 8. Australia: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 9. Australia: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 10. South Korea: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 11. South Korea: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 12. Rest of Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by Nutrient Type
Table 13. Rest of Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 14. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 15. Glossary of Terms, Parenteral Nutrition Market

LIST OF FIGURES

Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Parenteral Nutrition Market Share (%) – by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) – by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific: Parenteral Nutrition Market, by Key Country – Revenue (2022) (US$ Million)
Figure 16. Asia Pacific: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. China: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)
Figure 18. Japan: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)
Figure 19. India: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)
Figure 20. Australia: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)
Figure 21. South Korea: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)
Figure 22. Rest of Asia Pacific: Parenteral Nutrition Market – Revenue and Forecast to 2030(US$ Million)